🔗 Permalink

Inventor profile of:

Mark Barry Abelson

City:

Andover, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2021-09-23

Top Assignees for applications by Mark Barry Abelson

The entities that hold a legal rights for patent applications filed by inventor Abelson Mark Barry:

ACIEX THERAPEUTICS, INC. 4 Boston, MA United States
ACIEX THERAPEUTICS, INC. 4 Westborough, MA United States
NICOX OPHTHALMICS, INC. 3 Durham, NC United States
Nicox Ophthalmics, Inc. 2 Fort Worth, TX United States
Aciex, Inc. 1 Westborough, MA United States
NICOX OPTHALMICS, INC. 1 Fort Worth, TX United States

Recent patent applications by Abelson Mark Barry

Mark Barry Abelson from Andover, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-09-23

US20210290617A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#2 | 2021-06-17

US20210177807A1

Human necessities

COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING

#3 | 2020-12-31

US20200405711A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#4 | 2020-09-24

US20200297719A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#5 | 2018-10-04

US20180280383A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#6 | 2017-06-29

US20170182035A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#7 | 2017-03-23

US20170079957A1

Human necessities

COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING

#8 | 2016-04-21

US20160106666A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#9 | 2014-12-11

US20140364475A1

Human necessities

COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF EYELID SWELLING

#10 | 2014-06-12

US20140161903A1

Human necessities

Compositions for the Treatment and Prevention of Eyelid Swelling

#11 | 2014-02-13

US20140045803A1

Human necessities

Ophthalmic Formulations Of Cetirizine And Methods Of Use

#12 | 2013-09-26

US20130252971A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#13 | 2012-01-26

US20120021072A1

Human necessities

Compositions For The Treatment And Prevention Of Eyelid Swelling

#14 | 2011-10-20

US20110257136A1

Human necessities

Ophthalmic formulations of cetirizine and methods of use

#15 | 2011-05-05

US20110105450A1

Human necessities

OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE

#16 | 2009-05-28

US20090136598A1

Human necessities

Compositions for the Treatment and Prevention of Eyelid Swelling

#17 | 2007-11-15

US20070264318A1

Human necessities

Method for the treatment and prevention of eyelid swelling

InventorID:

457287 ⎘